12:14 PM EST - Labopharm Inc. : said it has received an approvable letter from the U.S. Food and Drug Administration for its once-daily formulation of the pain-killer tramadol, outlining requirements for full approval. Labopharm Inc.
T.DDS are trading down $1.61 at $6.50.
